APA (7th ed.) Citation

Florou, D., Katsara, M., Feehan, J., Dardiotis, E., & Apostolopoulos, V. (2020). Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab. Brain sciences, 10(10), 758. https://doi.org/10.3390/brainsci10100758

Chicago Style (17th ed.) Citation

Florou, Despoina, Maria Katsara, Jack Feehan, Efthimios Dardiotis, and Vasso Apostolopoulos. "Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab." Brain Sciences 10, no. 10 (2020): 758. https://doi.org/10.3390/brainsci10100758.

MLA (9th ed.) Citation

Florou, Despoina, et al. "Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab." Brain Sciences, vol. 10, no. 10, 2020, p. 758, https://doi.org/10.3390/brainsci10100758.